Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank71
Studio
Year-over-Year Change

Free cash flow yield

Latest
-17.72%
↑ 82% vs avg
Percentile
P71
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-96.78%
Historical baseline
PeriodValueYoY Change
2024-17.72%+6.2%
2023-18.89%+39.0%
2022-30.97%-251.7%
2021-8.81%+91.8%
2020-107.79%-57.4%
2019-68.49%+68.0%
2018-213.93%+1.3%
2017-216.81%-67.4%
2016-129.55%+16.3%
2015-154.82%-